Venturi Wealth Management LLC Has $176,000 Position in Humana Inc. (NYSE:HUM)

Venturi Wealth Management LLC raised its stake in shares of Humana Inc. (NYSE:HUM) by 628.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 692 shares of the insurance provider’s stock after buying an additional 597 shares during the period. Venturi Wealth Management LLC’s holdings in Humana were worth $176,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Creative Financial Designs Inc. ADV boosted its stake in shares of Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after buying an additional 61 shares during the period. Ashton Thomas Securities LLC acquired a new stake in shares of Humana in the 3rd quarter valued at $31,000. Your Advocates Ltd. LLP lifted its stake in shares of Humana by 81.8% in the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 45 shares during the last quarter. Atwood & Palmer Inc. lifted its stake in shares of Humana by 64.5% in the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock valued at $39,000 after purchasing an additional 60 shares during the last quarter. Finally, LRI Investments LLC lifted its stake in shares of Humana by 1,021.4% in the 3rd quarter. LRI Investments LLC now owns 157 shares of the insurance provider’s stock valued at $50,000 after purchasing an additional 143 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on HUM shares. JPMorgan Chase & Co. reduced their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research note on Tuesday. Barclays lifted their price objective on shares of Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a research note on Thursday, February 13th. Bank of America raised shares of Humana from an “underperform” rating to a “neutral” rating and lifted their price objective for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Nineteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $285.68.

Insider Activity at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now owns 8,181 shares of the company’s stock, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.32% of the stock is currently owned by insiders.

Humana Stock Performance

NYSE:HUM opened at $255.77 on Friday. The firm’s 50-day moving average is $269.41 and its 200-day moving average is $290.45. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The company has a market cap of $30.80 billion, a price-to-earnings ratio of 25.71, a PEG ratio of 2.00 and a beta of 0.56.

Humana (NYSE:HUM) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Equities research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a yield of 1.38%. Humana’s payout ratio is currently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.